Other licences also granted include an import licence by the ODC, and a wholesale licence from QLD Health. MedReleaf Australia will shortly be importing medicinal cannabis oils and capsules from our Canadian partner, MedReleaf Corp.

MedReleaf Corp. is a leading licensed producer of medical-grade cannabis products in Canada, and was recently named ‘Licensed Producer of the Year’ at the Canadian Cannabis Awards.

MedReleaf Corp. maintains a strong commitment to clinical trials and medical studies. Some completed and in-progress initiatives in Canada include a Pharmacokinetics trial, a Phase II cancer pain trial, a Phase III epilepsy trial, an observational chronic pain study, and a study to assess the potential correlation between genetic signatures and cannabis efficacy.

For further information about our joint venture partner, go to www.medreleaf.com and www.medreleaf.auroramj.com

    KEY MANAGEMENT TEAM

    Our management team is led by our Executive Chairman and CEO, Mr Russell Harding, and Director, Mr Neil Closner. We have assembled a management team and advisory panel that will ensure we can develop a wide distribution network to our key customers, Australian community and hospital pharmacies. Our strategy is to further strengthen the Board with additional commercial experience as required.

     

    Russell Harding

    BPharm, BHMS, MACP – Executive Chairman & CEO

    Russell is Co-founder of MedReleaf Australia, and has over 35 years’ experience as a successful pharmacy entrepreneur in Australia, solely responsible for six start-ups. Hardings Pharmacy at Annerley, Brisbane, established over 30 years ago, is the only 24-hour community pharmacy in Brisbane and was the first in Queensland to be accredited under the QCPP guidelines. He is a long-term Director and recent Chairman of a pharmaceutical warehousing co-operative company with over 80 pharmacy owners as members.

    – “We will strive to produce safe and effective cannabis medicines that will make a difference to the lives of Australians suffering painful, debilitating disease.”

     

    Aurora Cannabis / MedReleaf  Corp.

    Director – TBA

    To be appointed upon completion of Aurora Cannabis and MedReleaf Corp Integration.

     

    Nathan Davis

    Head of Strategy and Business Development

    Nathan is a Co-founder of MedReleaf Australia with Russell Harding. For almost 10 years, he worked for Australian Pharmaceutical Industries (API), the largest diversified wholesaler and franchisor of pharmaceutical products in Australia. Nathan established himself as a leader within the business, and was pivotal in the distribution and wholesale channels. He has a firm foundation of knowledge of the PBS, private and generic medicine marketplace in Australia. He is adept at realising, developing and actioning new and innovative business strategies.

    Gordon Chan

    BPharm, Grad Dip Hosp Pharm, BCNP, RPSS, MRACI CChem – Head of QA, Compliance and Regulatory Affairs

    Gordon Chan is currently Head of Radiopharmacy, Molecular Imaging & Therapy Austin Health, Austin Hospital, Victoria. Gordon is an experienced and highly regarded pharmacist who regularly presents at international conferences. Through his successful registration of over 10 radiopharmaceuticals through the TGA, Gordon has acquired the necessary regulatory experience and know-how to help bring MedReleaf Australia products to ARTG status and to the PBS – our ultimate goal. He has strong knowledge of TGA processes and remains motivated to deliver safe and effective medicines to the Australian public.

    KEY ADVISORS


    Debbie Rigby

    BPharm, Grad Dip Clin Pharm, Adv Pract Pharm – Head of Education
    • Consultant Clinical Pharmacist from Brisbane
    • Voted ‘Most Influential Woman in Pharmacy’ in Australia in 2016

     


    Professor Lisa Nissen

    BPharm, PhD, Adv Pract Pharm – Head of Research
    • Head of the School of Clinical Sciences at QUT, and Associate Professor at The University of Queensland
    • One of Australia’s first credentialed Advanced Pharmacy Practitioners, and regarded as one of the most influential people in pharmacy in Australia

     


    John Dunleavy

    CA, Barrister, BComm, BAB – Strategic Advisor
    • Chartered Accountant, Licensed Customs Broker and qualified Barrister in the Supreme Court of Queensland
    • Heads up Intertrade Advisers, a successful consulting practice, established in 1995

     


    Roy Mazucco

    PhD, BSc (Hons) – Head of Medical Communications
    • Manager at business consultancy Intertrade Advisers, Brisbane
    • Over 12 years’ experience working in Medical Communications in London, UK

     


    Stephanie Reuter Lange

    PhD, BSc (Hons) – Clinical Trial Lead
    • Senior Research Fellow at the School of Pharmacy and Medical Sciences, University of South Australia

     


    Stuart Larsson

    Head Grower
    • Founder and Managing Director of Mara Seeds, Australia’s biggest organic soy bean producer
    • Undertakes hemp growth trials